Wearable-Based Assessment of Cardiac Recovery After a Modified Bruce Test in Women with Breast Cancer: Role of Physical Activity and Treatment Duration.

Heart rate recovery (HRR) is an important indicator of cardiovascular autonomic function, yet evidence in women with breast cancer remains limited. This study aimed to analyze heart rate recovery during the first two minutes following a maximal exercise test and to examine its association with age, weekly physical activity, and oncological treatment duration using wearable technology. A cross-sectional design was applied in 22 women with breast cancer enrolled in an oncological exercise program. Participants performed a maximal treadmill test using the Modified Bruce Protocol, after which the mean heart rate was recorded across eight 15 s recovery intervals using a wearable chest-strap heart rate sensor integrated with an inertial device (WIMU PRO). Results showed a progressive and significant decrease in heart rate during recovery, with the first statistically significant pairwise difference emerging at 45-60 s post-exercise compared to the initial recovery interval ( < 0.05), within the context of a continuous HR decline. Regression analysis identified weekly physical activity hours (β = -0.281, = 0.013) and oncological treatment duration (β = -0.245, = 0.038) as significant predictors of mean heart rate recovery, explaining 4.8% of the variance, while age was not significantly associated (β = 0.049, = 0.622). In conclusion, a differentiated recovery pattern emerged at approximately 45-60 s post-exercise, with weekly physical activity and oncological treatment duration as determinants. These findings support the use of wearable-based monitoring to inform individualized exercise prescription in women with breast cancer.